Trulieve Cannabis (TCNNF) Capital Expenditures (2020 - 2026)

Trulieve Cannabis' Capital Expenditures history runs 7 years deep, the most recent figure standing at $4.7 million for Q1 2026.

• In Q1 2026, Capital Expenditures rose 63.29% year-over-year to $4.7 million; the TTM figure through Mar 2026 stood at $5.5 million (up 175.61% YoY), while the FY2025 annual figure was $3.7 million, down 30.34% from the prior year.
• Capital Expenditures was $4.7 million for Q1 2026 at Trulieve Cannabis, up from -$8.9 million in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $90.7 million in Q2 2022 to a low of -$126.5 million in Q4 2022.
• Historically, Capital Expenditures has averaged $1.7 million across 5 years, with a median of $3.4 million in 2023.
• The sharpest annual moves came in 2022 and 2024: Capital Expenditures surged 9574.6% in 2022, then sank 2694.47% in 2024.
• A 5-year view of Capital Expenditures shows it stood at -$126.5 million in 2022, then surged by 102.27% to $2.9 million in 2023, then tumbled by 2694.47% to -$74.6 million in 2024, then jumped by 88.05% to -$8.9 million in 2025, then surged by 152.28% to $4.7 million in 2026.
• The last three Capital Expenditures figures came in at $4.7 million (Q1 2026), -$8.9 million (Q4 2025), and $11.2 million (Q3 2025), per Business Quant data.